A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

BACKGROUND: The safety of the immune complexes composed of yeast-derived hepatitis B surface antigen (HBsAg) and antibodies (abbreviated as YIC) among healthy adults and chronic hepatitis B patients has been proved in phase I and phase IIa trial. A larger number of patients for study of dosage and e...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dao-Zhen Xu, Kai Zhao, Li-Min Guo, Lan-Juan Li, Qing Xie, Hong Ren, Ji-Ming Zhang, Min Xu, Hui-Fen Wang, Wen-Xiang Huang, Xue-Fan Bai, Jun-Qi Niu, Pei Liu, Xin-Yue Chen, Xin-Liang Shen, Zheng-Hong Yuan, Xuan-Yi Wang, Yu-Mei Wen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Public Library of Science (PLoS) 2008-01-01
Sarja:	PLoS ONE
Linkit:	http://europepmc.org/articles/PMC2430617?pdf=render
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!